Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Adds On 5 Points. More details...
CBT 200 Off by 8 Points. More details...
CBT 200 Shows Relative Strength. More details...
CBT 200 Slips .78%. More details...
CBT 200 Gives Up 13 Points. More details...
65th Annual Meeting Showcases Impending Drugs. More...
Another Genomics Guru Calls It Quits, Stock Rises. More...
CBT 200 Off By 20 Points. More details...
CBT 200 Climbs 1.52%. More details...
CBT 200 Drops 8 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
